Everence Capital Management Inc Meridian Bioscience Inc Transaction History

Everence Capital Management Inc

  • $1.44 Billion
  • Q2 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2022

Apr 11, 2022
BUY
$19.97 - $26.94 $170,144 - $229,528
8,520 New
8,520 $221,000
Q2 2021

Jul 12, 2021
SELL
$18.01 - $28.32 $153,445 - $241,286
-8,520 Closed
0 $0
Q1 2021

Apr 06, 2021
SELL
$19.76 - $29.89 $87,734 - $132,711
-4,440 Reduced 34.26%
8,520 $224,000
Q3 2020

Feb 01, 2021
BUY
$13.54 - $26.41 $175,478 - $342,273
12,960 New
12,960 $220,000

Others Institutions Holding VIVO

# of Institutions
10
Shares Held
113K
Call Options Held
0
Put Options Held
0
View Full List

About MERIDIAN BIOSCIENCE INC

VIVO Quotes by TradingView
  • Ticker VIVO
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 43,748,000
  • Description
  • Meridian Bioscience, Inc., a life science company, develops, manufactures, distributes, and sells diagnostic test kits primarily for gastrointestinal and respiratory infectious diseases, and elevated blood lead levels worldwide. The company operates through Diagnostics and Life Science segments. The Diagnostics segment offers testing platforms, ...
More about VIVO
Track This Portfolio

Track Everence Capital Management Inc Portfolio

Follow Everence Capital Management Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Everence Capital Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Everence Capital Management Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email